Your browser doesn't support javascript.
loading
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.
Nie, Lei; Wang, Ying-Nai; Hsu, Jung-Mao; Hou, Junwei; Chu, Yu-Yi; Chan, Li-Chuan; Huo, Longfei; Wei, Yongkun; Deng, Rong; Tang, Jun; Hsu, Yi-Hsin; Ko, How-Wen; Lim, Seung-Oe; Huang, Kebin; Chen, Mei-Kuang; Chiu, Tai-Jan; Cheng, Chien-Chia; Fang, Yueh-Fu; Li, Chia-Wei; Goverdhan, Aarthi; Wu, Hsing-Ju; Lee, Cheng-Chung; Wang, Wen-Ling; Hsu, Jennifer; Chiao, Paul; Wang, Shao-Chun; Hung, Mien-Chie.
Afiliación
  • Nie L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Wang YN; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Hsu JM; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Hou J; Center for Molecular Medicine, China Medical University Hospital Taichung, Taiwan.
  • Chu YY; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Chan LC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Huo L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Wei Y; UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Deng R; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Tang J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Hsu YH; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Ko HW; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China.
  • Lim SO; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Huang K; Department of Breast Oncology, Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China.
  • Chen MK; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Chiu TJ; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Cheng CC; UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Fang YF; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine Taoyuan, Taiwan.
  • Li CW; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Goverdhan A; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Wu HJ; State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Pharmacy, Guangxi Normal University Guilin, Guangxi, China.
  • Lee CC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Wang WL; UTHealth Houston Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Hsu J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Chiao P; Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung, Taiwan.
  • Wang SC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
  • Hung MC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas, USA.
Am J Cancer Res ; 13(4): 1209-1239, 2023.
Article en En | MEDLINE | ID: mdl-37168336
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos